Disclaimer

This example is for illustration purposes only. The data provided may not be up-to-date, and in some cases, 'dummy' data has been included. The product information included here shall not be used for any other purpose than for educational purposes regarding the IDMP-O implementation.

Introduction

Nexavar, co-developed by Bayer and Onyx Pharmaceuticals, is a drug that has been approved for the treatment of various cancers, and is presented as tablets containing 274 mg of sorafenib tosylate. As shown in the diagram below, the reference substance for sorafenib tosylate is sorafenib with a reference strength of 200 mg per tablet.

...